Revolution Medicines, Inc. (RVMD)
79.07
+1.26
(+1.62%)
USD |
NASDAQ |
Dec 10, 09:47
Revolution Medicines EPS Diluted (Quarterly): -1.613 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Disc Medicine, Inc. | -1.772 |
| KalVista Pharmaceuticals, Inc. | -0.9183 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Electromed, Inc. | 0.246 |
| Xtant Medical Holdings, Inc. | 0.0087 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -305.21M |
| Total Expenses (Quarterly) | 305.21M |
| Enterprise Value | 13.27B |
| Earnings Yield | -6.55% |
| Normalized Earnings Yield | -6.538 |